Pharma execs say they support generic sampling access
Seven pharmaceutical executives have said they support efforts by Congress to increase generic drugmakers' access to samples of brand-name medication.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10